annual CFO:
$25.69M+$12.39M(+93.14%)Summary
- As of today (June 2, 2025), KNSA annual cash flow from operations is $25.69 million, with the most recent change of +$12.39 million (+93.14%) on December 31, 2024.
- During the last 3 years, KNSA annual CFO has risen by +$151.99 million (+120.34%).
- KNSA annual CFO is now at all-time high.
Performance
KNSA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$22.32M+$3.55M(+18.93%)Summary
- As of today (June 2, 2025), KNSA quarterly cash flow from operations is $22.32 million, with the most recent change of +$3.55 million (+18.93%) on March 31, 2025.
- Over the past year, KNSA quarterly CFO has increased by +$18.34 million (+459.92%).
- KNSA quarterly CFO is now -64.02% below its all-time high of $62.05 million, reached on September 30, 2022.
Performance
KNSA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$44.03M+$18.34M(+71.38%)Summary
- As of today (June 2, 2025), KNSA TTM cash flow from operations is $44.03 million, with the most recent change of +$18.34 million (+71.38%) on March 31, 2025.
- Over the past year, KNSA TTM CFO has increased by +$22.47 million (+104.25%).
- KNSA TTM CFO is now at all-time high.
Performance
KNSA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KNSA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +93.1% | +459.9% | +104.3% |
| 3 y3 years | +120.3% | +160.6% | +135.8% |
| 5 y5 years | +116.2% | +170.2% | +134.7% |
KNSA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.3% | -64.0% | +160.6% | at high | +135.8% |
| 5 y | 5-year | at high | +116.2% | -64.0% | +154.2% | at high | +128.5% |
| alltime | all time | at high | +116.2% | -64.0% | +135.3% | at high | +127.2% |
KNSA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $22.32M(+18.9%) | $44.03M(+71.4%) |
| Dec 2024 | $25.69M(+93.1%) | $18.77M(-939.4%) | $25.69M(+128.5%) |
| Sep 2024 | - | -$2.24M(-143.3%) | $11.24M(-63.1%) |
| Jun 2024 | - | $5.17M(+29.6%) | $30.47M(+41.3%) |
| Mar 2024 | - | $3.99M(-7.8%) | $21.55M(+62.1%) |
| Dec 2023 | $13.30M(+129.1%) | $4.33M(-74.5%) | $13.30M(-611.6%) |
| Sep 2023 | - | $16.99M(-553.8%) | -$2.60M(-106.1%) |
| Jun 2023 | - | -$3.74M(-12.3%) | $42.47M(+10.6%) |
| Mar 2023 | - | -$4.27M(-63.1%) | $38.39M(+561.0%) |
| Dec 2022 | $5.81M(-104.6%) | -$11.58M(-118.7%) | $5.81M(-486.9%) |
| Sep 2022 | - | $62.05M(-893.1%) | -$1.50M(-98.4%) |
| Jun 2022 | - | -$7.82M(-78.8%) | -$92.06M(-25.2%) |
| Mar 2022 | - | -$36.85M(+95.1%) | -$123.02M(-2.6%) |
| Dec 2021 | -$126.30M(-7.5%) | -$18.88M(-33.8%) | -$126.30M(-15.0%) |
| Sep 2021 | - | -$28.51M(-26.5%) | -$148.60M(-3.8%) |
| Jun 2021 | - | -$38.78M(-3.3%) | -$154.42M(+6.6%) |
| Mar 2021 | - | -$40.12M(-2.6%) | -$144.86M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$136.53M(-13.8%) | -$41.19M(+20.0%) | -$136.53M(+14.2%) |
| Sep 2020 | - | -$34.32M(+17.4%) | -$119.51M(+4.4%) |
| Jun 2020 | - | -$29.22M(-8.1%) | -$114.46M(-9.8%) |
| Mar 2020 | - | -$31.80M(+31.6%) | -$126.91M(-19.9%) |
| Dec 2019 | -$158.37M(+95.5%) | -$24.17M(-17.4%) | -$158.37M(-2.1%) |
| Sep 2019 | - | -$29.27M(-29.8%) | -$161.84M(+5.7%) |
| Jun 2019 | - | -$41.68M(-34.1%) | -$153.06M(+18.4%) |
| Mar 2019 | - | -$63.26M(+128.9%) | -$129.30M(+59.6%) |
| Dec 2018 | -$81.01M(+61.3%) | -$27.64M(+34.9%) | -$81.01M(+5.5%) |
| Sep 2018 | - | -$20.48M(+14.3%) | -$76.75M(+14.2%) |
| Jun 2018 | - | -$17.92M(+19.7%) | -$67.21M(+12.9%) |
| Mar 2018 | - | -$14.97M(-36.0%) | -$59.51M(+18.5%) |
| Dec 2017 | -$50.22M(+129.7%) | -$23.38M(+113.6%) | -$50.22M(+87.1%) |
| Sep 2017 | - | -$10.94M(+7.1%) | -$26.84M(+68.8%) |
| Jun 2017 | - | -$10.22M(+79.9%) | -$15.90M(+179.9%) |
| Mar 2017 | - | -$5.68M | -$5.68M |
| Dec 2016 | -$21.87M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual CFO year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly CFO year-on-year change?
- What is Kiniksa Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM CFO year-on-year change?
What is Kiniksa Pharmaceuticals annual cash flow from operations?
The current annual CFO of KNSA is $25.69M
What is the all time high annual CFO for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash flow from operations is $25.69M
What is Kiniksa Pharmaceuticals annual CFO year-on-year change?
Over the past year, KNSA annual cash flow from operations has changed by +$12.39M (+93.14%)
What is Kiniksa Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of KNSA is $22.32M
What is the all time high quarterly CFO for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash flow from operations is $62.05M
What is Kiniksa Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, KNSA quarterly cash flow from operations has changed by +$18.34M (+459.92%)
What is Kiniksa Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of KNSA is $44.03M
What is the all time high TTM CFO for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM cash flow from operations is $44.03M
What is Kiniksa Pharmaceuticals TTM CFO year-on-year change?
Over the past year, KNSA TTM cash flow from operations has changed by +$22.47M (+104.25%)